Markets
Pfizer Stock: Is Its ‘Dead Money’ Tag Misleading?
Pfizer shares have fallen over 50% from their 2021 high, leading many to label it "dead money." However, a closer look reveals...

Pfizer shares have fallen over 50% from their 2021 high, leading many to label it "dead money." However, a closer look reveals...

Bristol Myers Squibb (BMY) shows compelling value with a low forward P/E and a 4.2% dividend yield, despite concerns over legacy drug...

Geopolitical jitters are creating a contrarian buying opportunity in high-yielding closed-end funds, with some offering dividends exceeding 10.7%. Analysts point to overlooked...

Citigroup's Board of Directors has declared a quarterly common stock dividend of $0.60 per share, alongside dividends for twelve series of preferred...